Boiron SA (BOI), a French maker of homeopathic remedies, fell the most since at least 1989 in Paris trading after reporting a slump in first-half earnings.
Boiron was recently on the skeptical radar for threatening to sue an Italian blogger who criticized their product oscillococcinum. Science-based medicine blog called this “thuggery” and the Center for Inquiry publicly invited Boiron to sue them. Therefore, the news that their bottom line is headed downwards is good news.
Credit: @krelnik (Tim Farley) on Twitter